New research on type 2 diabetes offers fresh hope for treatment
Scientists may be closer to a cure for Type 2 Diabetes than we think
Scientists at City of Hope have discovered a gene that plays a surprising role in the development of type 2 diabetes (T2D).
The gene, which is called SMOC1, seems to cause certain cells in the pancreas that are normally responsible for lowering blood sugar—to start doing the opposite and raise blood sugar instead.
These findings could open the door to new ways of treating, diagnosing, and possibly preventing T2D.
The study was published in Nature Communications and focused on understanding how insulin-producing cells in the pancreas disappear or stop working properly in people with diabetes.
The pancreas contains small clusters of cells known as islets. Within these islets, beta cells produce insulin, a hormone that lowers blood sugar, and alpha cells produce glucagon to raise blood sugar.
When produced properly by the pancreas the two hormones keep a healthy balance in the body, controlling blood sugar levels.
In people with type 2 diabetes, that balance is thrown off. Some beta cells begin to lose their identity.
Instead of producing insulin, they start acting like alpha cells and begin making glucagon. This leads to higher blood sugar levels and a worsening of diabetes.
To understand why this happens, scientists analyzed individual islet cells from 26 people—half had type 2 diabetes and the other half did not.
They used a powerful technique called RNA sequencing to study how the cells change over time.
The research team found that in healthy people, some cells were flexible and could mature into either alpha or beta cells.
But in people with diabetes, this flexibility was lost. Beta cells only transitioned into alpha cells, never the other way around. This one-way shift helps explain why insulin levels drop while glucagon levels rise in people with T2D.
This research does give hope that by targeting the root causes of type 2 diabetes at the genetic level, new treatments may one day be able to help millions of people better manage or even reverse their condition.
-
Richard Scolyer Dies at 59: Pioneer cancer researcher received world-first brain tumor treatment
-
New triple-action diabetes jab delivers impressive blood sugar and weight-loss results
-
WHO unveils $518 million strategy to curb Africa Ebola outbreak
-
US measles cases surge past 2,000 as outbreak continues to spread
-
AI breakthrough: ‘world’s first’ vaccine designed by AI enters human trials
-
New World Screwworm returns to US after 60 years, Texas case confirmed
-
NewLimit develops age-reversing drug, human clinical trial set for 2027
-
CDC warns emerging cosmetic procedures could pose fatal health risks
